glp-1 vs semaglutide Medications for Weight Loss: Tirzepatide vs Retat – Revolution Health & Wellness Tirzepatide vs Semaglutide | Understanding

Effects of glucagon-like peptide-1 receptor agonists on gastric mucosal visibility and retained gastric contents during EGD

Thank you for sharing Congrats to you and your team

Despite this, the FDA (Food and Drug Administration) expressed support for further testing in phase III trials, suggesting that tesofensine could be a safe and effective long-term treatment for obesity, with minimal effects on the cardiovascular system

Obesity will likely continue to be a nationwide problem due to easy access to unhealthy foods and limited access to healthy choices in many areas

Torekov SS, Madsbad S, & Holst JJ (2011)

One study with more than 300 participants saw a 15.8% decrease in body weight for semaglutide after 68 weeks.3 Another study saw a 12.4% decrease after 72 weeks.4 Averaging those two outcomes, someone weighing 200 pounds could reasonably expect to lose around 14% of their body weight after about 16 months